AssetMark Inc’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

AssetMark Inc’s Portfolio PTLA Stock Details PTLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-73	Closed	-$1K	–	1443
2020 Q2	$1K	Sell	73 -15	-17%	-$209	﹤0.01%	1239
2020 Q1	$1K	Buy	88 +4	+5%	+$50	﹤0.01%	1332
2019 Q4	$2K	Buy	84 +4	+5%	+$110	﹤0.01%	1280
2019 Q3	$2K	Buy	+80	New	+$2.25K	﹤0.01%	1201
2018 Q1	–	Sell	-6	Closed	–	–	2175
2017 Q4	$0	Buy	+6	New	+$303	﹤0.01%	2231
2016 Q1	–	Sell	-14	Closed	-$1K	–	1488
2015 Q4	$1K	Buy	+14	New	+$679	﹤0.01%	1318

AssetMark Inc's PTLA Position: Q3 2020 in Review

AssetMark Inc sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q3 2020, closing a stake of 73 shares — an estimated $1K sold.

AssetMark Inc first reported a position in PTLA in Q4 2015 and held it in 6 quarters. The position peaked at $2K in Q4 2019. 0 funds tracked by Wall St. Rank hold PTLA as of Q3 2020.

AssetMark Inc reported no remaining Portola Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
AssetMark Inc sold 73 Portola Pharmaceuticals, Inc. shares in Q3 2020, an estimated $1K.
AssetMark Inc first reported a position in Portola Pharmaceuticals, Inc. in Q4 2015 and held it in 6 quarters.
AssetMark Inc's Portola Pharmaceuticals, Inc. position peaked at $2K in Q4 2019.
0 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q3 2020.

Based on AssetMark Inc's 13F filing for Q3 2020, filed 13 Nov 2020.